跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XueBiJing
首页
药物
XueBiJing
XueBiJing
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Pharmaceutical composition for treating sepsis and use thereof
US 12616709 B2
申请人: TIANJIN CHASE SUN PHARMACEUTICAL CO LTD
优先权: 2021
CN
EP
US
WO
5 件公开
Quality-control method of a traditional Chinese medicine 'Xuebijing' injection
CN 101007072 B
申请人: TIANJIAN CHASESUN PHARMACEUTICAL CO LTD
优先权: 2007
CN
Xuebijing oral administration effervescing agent
CN 101317893 B
申请人: TIANJIAN CHASESUN PHARMACEUTICAL CO LTD
优先权: 2008
CN
Drying method of compound traditional Chinese medicine Xuebijin monarch drug extract
CN 101332217 B
申请人: TIANJIAN CHASESUN PHARMACEUTICAL CO LTD
优先权: 2008
CN
Application of Xuebijing in preparing medicament for treating paraquat poisoning
CN 101513455 A
申请人: UNIV JILIN
优先权: 2009
CN
Protective effect of Xuebijing injection on ionizing radiation induced mouse hemopoiesis injury
CN 103800454 A
申请人: INST RADIATION MEDICINE CHINESE ACADEMY MEDICAL SCIENCES
优先权: 2012
CN
Method of studying intervention of lung-clearing intestine-clearing mixture upon ARDS-causing (acute respiratory distress syndrome-causing) TNF and interleukin 8
CN 109364268 A
申请人: GANSU PROVINCIAL HOSPITAL OF TCM
优先权: 2018
CN
Application of Xuebijing components in preparation of medicine for regulating sepsis
CN 113116909 A
申请人: TIANJIN CHASESUN PHARM CO LTD
优先权: 2019
CN
Application of Xuebijing injection to preparation of medicine for inhibiting mRNA expression of IP-10 and RANTES
CN 113730461 A
申请人: TIANJIN CHASESUN PHARM CO LTD
优先权: 2020
CN
药物
反馈